The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis

We present a 31-year-old female who presented to the general surgical take with epigastric pain associated with a raised amylase and corrected calcium on admission. Computed tomography confirmed acute pancreatitis and also demonstrated a 15 cm liver tumour. She was subsequently diagnosed with cancer...

Full description

Bibliographic Details
Main Authors: Jayan George, Emily Reed, Kuunal Patel, James Gardner-Thorpe
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Reports
Subjects:
Online Access:https://www.mdpi.com/2571-841X/2/2/13
id doaj-f009c91f7fdf4edf820c682baf73d265
record_format Article
spelling doaj-f009c91f7fdf4edf820c682baf73d2652020-11-25T00:52:34ZengMDPI AGReports2571-841X2019-04-01221310.3390/reports2020013reports2020013The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with PancreatitisJayan George0Emily Reed1Kuunal Patel2James Gardner-Thorpe3General Surgical Department, Sheffield Teaching Hospitals NHS Foundation Trust, Herries Road, Sheffield S5 7AU, UKGeneral Surgical Department, Sheffield Teaching Hospitals NHS Foundation Trust, Herries Road, Sheffield S5 7AU, UKGeneral Surgical Department, Sheffield Teaching Hospitals NHS Foundation Trust, Herries Road, Sheffield S5 7AU, UKGeneral Surgical Department, Sheffield Teaching Hospitals NHS Foundation Trust, Herries Road, Sheffield S5 7AU, UKWe present a 31-year-old female who presented to the general surgical take with epigastric pain associated with a raised amylase and corrected calcium on admission. Computed tomography confirmed acute pancreatitis and also demonstrated a 15 cm liver tumour. She was subsequently diagnosed with cancer of unknown primary with liver metastases. The patient’s pancreatitis symptoms improved with conservative management, but her calcium proved quite resistant to basic measures. Further input was sought from the medical on-call endocrinology and oncology teams to help manage this patient’s hypercalcaemia, which included pamidronate, zolendronate, and denusomab, but ultimately it only improved significantly following chemotherapy. This case to our knowledge is the only one of its kind and highlights the importance of early multidisciplinary team involvement across specialties to help manage complex patients.https://www.mdpi.com/2571-841X/2/2/13hypercalcaemiapancreatitiscancer of unknown primarypositron emission tomography
collection DOAJ
language English
format Article
sources DOAJ
author Jayan George
Emily Reed
Kuunal Patel
James Gardner-Thorpe
spellingShingle Jayan George
Emily Reed
Kuunal Patel
James Gardner-Thorpe
The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
Reports
hypercalcaemia
pancreatitis
cancer of unknown primary
positron emission tomography
author_facet Jayan George
Emily Reed
Kuunal Patel
James Gardner-Thorpe
author_sort Jayan George
title The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
title_short The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
title_full The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
title_fullStr The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
title_full_unstemmed The Management of Resistant Hypercalcaemia Secondary to Cancer of Unknown Primary and Presenting with Pancreatitis
title_sort management of resistant hypercalcaemia secondary to cancer of unknown primary and presenting with pancreatitis
publisher MDPI AG
series Reports
issn 2571-841X
publishDate 2019-04-01
description We present a 31-year-old female who presented to the general surgical take with epigastric pain associated with a raised amylase and corrected calcium on admission. Computed tomography confirmed acute pancreatitis and also demonstrated a 15 cm liver tumour. She was subsequently diagnosed with cancer of unknown primary with liver metastases. The patient’s pancreatitis symptoms improved with conservative management, but her calcium proved quite resistant to basic measures. Further input was sought from the medical on-call endocrinology and oncology teams to help manage this patient’s hypercalcaemia, which included pamidronate, zolendronate, and denusomab, but ultimately it only improved significantly following chemotherapy. This case to our knowledge is the only one of its kind and highlights the importance of early multidisciplinary team involvement across specialties to help manage complex patients.
topic hypercalcaemia
pancreatitis
cancer of unknown primary
positron emission tomography
url https://www.mdpi.com/2571-841X/2/2/13
work_keys_str_mv AT jayangeorge themanagementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT emilyreed themanagementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT kuunalpatel themanagementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT jamesgardnerthorpe themanagementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT jayangeorge managementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT emilyreed managementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT kuunalpatel managementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
AT jamesgardnerthorpe managementofresistanthypercalcaemiasecondarytocancerofunknownprimaryandpresentingwithpancreatitis
_version_ 1725241640173436928